Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 12

1.

Ertapenem-resistant Enterobacteriaceae: risk factors for acquisition and outcomes.

Hyle EP, Ferraro MJ, Silver M, Lee H, Hooper DC.

Infect Control Hosp Epidemiol. 2010 Dec;31(12):1242-9. doi: 10.1086/657138. Epub 2010 Oct 28.

PMID:
21029005
[PubMed - indexed for MEDLINE]
2.

Extended-spectrum beta-lactamase-producing organisms.

Falagas ME, Karageorgopoulos DE.

J Hosp Infect. 2009 Dec;73(4):345-54. doi: 10.1016/j.jhin.2009.02.021. Epub 2009 Jul 10. Review.

PMID:
19596491
[PubMed - indexed for MEDLINE]
3.

Clinical significance of extended-spectrum beta-lactamases.

Rodríguez-Baño J, Pascual A.

Expert Rev Anti Infect Ther. 2008 Oct;6(5):671-83. doi: 10.1586/14787210.6.5.671. Review.

PMID:
18847405
[PubMed - indexed for MEDLINE]
4.

[KPC carbapenemases: what is at stake in clinical microbiology?].

Cuzon G, Naas T, Nordmann P.

Pathol Biol (Paris). 2010 Feb;58(1):39-45. doi: 10.1016/j.patbio.2009.07.026. Epub 2009 Oct 24. Review. French.

PMID:
19854586
[PubMed - indexed for MEDLINE]
5.

Multiresistant Enterobacteriaceae: new threat of an old problem.

Pitout JD.

Expert Rev Anti Infect Ther. 2008 Oct;6(5):657-69. doi: 10.1586/14787210.6.5.657. Review.

PMID:
18847404
[PubMed - indexed for MEDLINE]
6.

Optimizing therapy for infections caused by enterobacteriaceae producing extended-spectrum beta-lactamases.

Endimiani A, Paterson DL.

Semin Respir Crit Care Med. 2007 Dec;28(6):646-55. Review.

PMID:
18095228
[PubMed - indexed for MEDLINE]
7.

Extended-spectrum beta-lactamases (ESbLs): characterization, epidemiology and detection.

Shah AA, Hasan F, Ahmed S, Hameed A.

Crit Rev Microbiol. 2004;30(1):25-32. Review.

PMID:
15116761
[PubMed - indexed for MEDLINE]
8.

Resistance in gram-negative bacteria: enterobacteriaceae.

Paterson DL.

Am J Med. 2006 Jun;119(6 Suppl 1):S20-8; discussion S62-70. Review.

PMID:
16735147
[PubMed - indexed for MEDLINE]
9.

A review of multidrug-resistant Enterobacteriaceae.

Pereira EC, Shaw KM, Vagnone PM, Harper J, Lynfield R.

Minn Med. 2011 Oct;94(10):44-8. Review.

PMID:
23256284
[PubMed - indexed for MEDLINE]
10.

Carbapenem-resistant Enterobacteriaceae: a review of treatment and outcomes.

van Duin D, Kaye KS, Neuner EA, Bonomo RA.

Diagn Microbiol Infect Dis. 2013 Feb;75(2):115-20. doi: 10.1016/j.diagmicrobio.2012.11.009. Epub 2013 Jan 3. Review.

PMID:
23290507
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

The efficacy of infection control interventions in reducing the incidence of extended-spectrum β-lactamase-producing Enterobacteriaceae in the nonoutbreak setting: A systematic review.

Goddard S, Muller MP.

Am J Infect Control. 2011 Sep;39(7):599-601. doi: 10.1016/j.ajic.2010.09.018. Epub 2011 May 31. Review.

PMID:
21621295
[PubMed - indexed for MEDLINE]
12.

Priorities in the prevention and control of multidrug-resistant Enterobacteriaceae in hospitals.

Khan AS, Dancer SJ, Humphreys H.

J Hosp Infect. 2012 Oct;82(2):85-93. doi: 10.1016/j.jhin.2012.06.013. Epub 2012 Aug 3. Review.

PMID:
22863084
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk